Request for Covid-19 Impact Assessment of this Report
The United States Prostate Cancer Diagnosis and Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prostate Cancer Diagnosis and Therapy market, reaching US$ million by the year 2028. As for the Europe Prostate Cancer Diagnosis and Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Prostate Cancer Diagnosis and Therapy players cover AbbVie, Astellas Pharma, AstraZeneca, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnosis and Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
General Hospitals
Specialty Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Diagnosis and Therapy Market Size 2017-2028
2.1.2 Prostate Cancer Diagnosis and Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Prostate Cancer Diagnosis and Therapy Segment by Type
2.2.1 Hormone Therapy
2.2.2 Chemotherapy
2.2.3 Biologic Therapy
2.2.4 Targeted Therapy
2.3 Prostate Cancer Diagnosis and Therapy Market Size by Type
2.3.1 Prostate Cancer Diagnosis and Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
2.4 Prostate Cancer Diagnosis and Therapy Segment by Application
2.4.1 General Hospitals
2.4.2 Specialty Clinics
2.5 Prostate Cancer Diagnosis and Therapy Market Size by Application
2.5.1 Prostate Cancer Diagnosis and Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
3 Prostate Cancer Diagnosis and Therapy Market Size by Player
3.1 Prostate Cancer Diagnosis and Therapy Market Size Market Share by Players
3.1.1 Global Prostate Cancer Diagnosis and Therapy Revenue by Players (2020-2022)
3.1.2 Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Prostate Cancer Diagnosis and Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Diagnosis and Therapy by Regions
4.1 Prostate Cancer Diagnosis and Therapy Market Size by Regions (2017-2022)
4.2 Americas Prostate Cancer Diagnosis and Therapy Market Size Growth (2017-2022)
4.3 APAC Prostate Cancer Diagnosis and Therapy Market Size Growth (2017-2022)
4.4 Europe Prostate Cancer Diagnosis and Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Prostate Cancer Diagnosis and Therapy Market Size by Country (2017-2022)
5.2 Americas Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022)
5.3 Americas Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Diagnosis and Therapy Market Size by Region (2017-2022)
6.2 APAC Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022)
6.3 APAC Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Therapy by Country (2017-2022)
7.2 Europe Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022)
7.3 Europe Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Diagnosis and Therapy by Region (2017-2022)
8.2 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Cancer Diagnosis and Therapy Market Forecast
10.1 Global Prostate Cancer Diagnosis and Therapy Forecast by Regions (2023-2028)
10.1.1 Global Prostate Cancer Diagnosis and Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Prostate Cancer Diagnosis and Therapy Forecast
10.1.3 APAC Prostate Cancer Diagnosis and Therapy Forecast
10.1.4 Europe Prostate Cancer Diagnosis and Therapy Forecast
10.1.5 Middle East & Africa Prostate Cancer Diagnosis and Therapy Forecast
10.2 Americas Prostate Cancer Diagnosis and Therapy Forecast by Country (2023-2028)
10.2.1 United States Prostate Cancer Diagnosis and Therapy Market Forecast
10.2.2 Canada Prostate Cancer Diagnosis and Therapy Market Forecast
10.2.3 Mexico Prostate Cancer Diagnosis and Therapy Market Forecast
10.2.4 Brazil Prostate Cancer Diagnosis and Therapy Market Forecast
10.3 APAC Prostate Cancer Diagnosis and Therapy Forecast by Region (2023-2028)
10.3.1 China Prostate Cancer Diagnosis and Therapy Market Forecast
10.3.2 Japan Prostate Cancer Diagnosis and Therapy Market Forecast
10.3.3 Korea Prostate Cancer Diagnosis and Therapy Market Forecast
10.3.4 Southeast Asia Prostate Cancer Diagnosis and Therapy Market Forecast
10.3.5 India Prostate Cancer Diagnosis and Therapy Market Forecast
10.3.6 Australia Prostate Cancer Diagnosis and Therapy Market Forecast
10.4 Europe Prostate Cancer Diagnosis and Therapy Forecast by Country (2023-2028)
10.4.1 Germany Prostate Cancer Diagnosis and Therapy Market Forecast
10.4.2 France Prostate Cancer Diagnosis and Therapy Market Forecast
10.4.3 UK Prostate Cancer Diagnosis and Therapy Market Forecast
10.4.4 Italy Prostate Cancer Diagnosis and Therapy Market Forecast
10.4.5 Russia Prostate Cancer Diagnosis and Therapy Market Forecast
10.5 Middle East & Africa Prostate Cancer Diagnosis and Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Prostate Cancer Diagnosis and Therapy Market Forecast
10.5.2 South Africa Prostate Cancer Diagnosis and Therapy Market Forecast
10.5.3 Israel Prostate Cancer Diagnosis and Therapy Market Forecast
10.5.4 Turkey Prostate Cancer Diagnosis and Therapy Market Forecast
10.5.5 GCC Countries Prostate Cancer Diagnosis and Therapy Market Forecast
10.6 Global Prostate Cancer Diagnosis and Therapy Forecast by Type (2023-2028)
10.7 Global Prostate Cancer Diagnosis and Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Prostate Cancer Diagnosis and Therapy Product Offered
11.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Information
11.2.2 Astellas Pharma Prostate Cancer Diagnosis and Therapy Product Offered
11.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Astellas Pharma Main Business Overview
11.2.5 Astellas Pharma Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Prostate Cancer Diagnosis and Therapy Product Offered
11.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Prostate Cancer Diagnosis and Therapy Product Offered
11.4.3 Bayer Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Dendreon Pharmaceuticals
11.5.1 Dendreon Pharmaceuticals Company Information
11.5.2 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offered
11.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Dendreon Pharmaceuticals Main Business Overview
11.5.5 Dendreon Pharmaceuticals Latest Developments
11.6 Ferring
11.6.1 Ferring Company Information
11.6.2 Ferring Prostate Cancer Diagnosis and Therapy Product Offered
11.6.3 Ferring Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Ferring Main Business Overview
11.6.5 Ferring Latest Developments
11.7 Ipsen Pharma
11.7.1 Ipsen Pharma Company Information
11.7.2 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product Offered
11.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Ipsen Pharma Main Business Overview
11.7.5 Ipsen Pharma Latest Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Information
11.8.2 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product Offered
11.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Johnson and Johnson Main Business Overview
11.8.5 Johnson and Johnson Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Prostate Cancer Diagnosis and Therapy Product Offered
11.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Tolmar Pharmaceuticals
11.10.1 Tolmar Pharmaceuticals Company Information
11.10.2 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offered
11.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Tolmar Pharmaceuticals Main Business Overview
11.10.5 Tolmar Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Prostate Cancer Diagnosis and Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Hormone Therapy
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Biologic Therapy
Table 5. Major Players of Targeted Therapy
Table 6. Prostate Cancer Diagnosis and Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
Table 9. Prostate Cancer Diagnosis and Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
Table 12. Global Prostate Cancer Diagnosis and Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Player (2020-2022)
Table 14. Prostate Cancer Diagnosis and Therapy Key Players Head office and Products Offered
Table 15. Prostate Cancer Diagnosis and Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Prostate Cancer Diagnosis and Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Regions (2017-2022)
Table 20. Americas Prostate Cancer Diagnosis and Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Prostate Cancer Diagnosis and Therapy Market Size Market Share by Country (2017-2022)
Table 22. Americas Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
Table 24. Americas Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
Table 26. APAC Prostate Cancer Diagnosis and Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Prostate Cancer Diagnosis and Therapy Market Size Market Share by Region (2017-2022)
Table 28. APAC Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
Table 30. APAC Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
Table 32. Europe Prostate Cancer Diagnosis and Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Country (2017-2022)
Table 34. Europe Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
Table 36. Europe Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Prostate Cancer Diagnosis and Therapy
Table 45. Key Market Challenges & Risks of Prostate Cancer Diagnosis and Therapy
Table 46. Key Industry Trends of Prostate Cancer Diagnosis and Therapy
Table 47. Global Prostate Cancer Diagnosis and Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Prostate Cancer Diagnosis and Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Prostate Cancer Diagnosis and Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 53. AbbVie Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 54. AbbVie Prostate Cancer Diagnosis and Therapy Product Offered
Table 55. AbbVie Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Astellas Pharma Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 59. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product Offered
Table 60. Astellas Pharma Main Business
Table 61. Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Astellas Pharma Latest Developments
Table 63. AstraZeneca Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 64. AstraZeneca Prostate Cancer Diagnosis and Therapy Product Offered
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. AstraZeneca Latest Developments
Table 68. Bayer Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 69. Bayer Prostate Cancer Diagnosis and Therapy Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Bayer Latest Developments
Table 73. Dendreon Pharmaceuticals Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 74. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offered
Table 75. Dendreon Pharmaceuticals Main Business
Table 76. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Dendreon Pharmaceuticals Latest Developments
Table 78. Ferring Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 79. Ferring Prostate Cancer Diagnosis and Therapy Product Offered
Table 80. Ferring Main Business
Table 81. Ferring Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Ferring Latest Developments
Table 83. Ipsen Pharma Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 84. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product Offered
Table 85. Ipsen Pharma Main Business
Table 86. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Ipsen Pharma Latest Developments
Table 88. Johnson and Johnson Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 89. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product Offered
Table 90. Johnson and Johnson Main Business
Table 91. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Johnson and Johnson Latest Developments
Table 93. Sanofi Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 94. Sanofi Prostate Cancer Diagnosis and Therapy Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Sanofi Latest Developments
Table 98. Tolmar Pharmaceuticals Details, Company Type, Prostate Cancer Diagnosis and Therapy Area Served and Its Competitors
Table 99. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offered
Table 100. Tolmar Pharmaceuticals Main Business
Table 101. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Tolmar Pharmaceuticals Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnosis and Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Diagnosis and Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type in 2021
Figure 7. Prostate Cancer Diagnosis and Therapy in General Hospitals
Figure 8. Global Prostate Cancer Diagnosis and Therapy Market: General Hospitals (2017-2022) & ($ Millions)
Figure 9. Prostate Cancer Diagnosis and Therapy in Specialty Clinics
Figure 10. Global Prostate Cancer Diagnosis and Therapy Market: Specialty Clinics (2017-2022) & ($ Millions)
Figure 11. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application in 2021
Figure 12. Global Prostate Cancer Diagnosis and Therapy Revenue Market Share by Player in 2021
Figure 13. Global Prostate Cancer Diagnosis and Therapy Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Prostate Cancer Diagnosis and Therapy Market Size 2017-2022 ($ Millions)
Figure 15. APAC Prostate Cancer Diagnosis and Therapy Market Size 2017-2022 ($ Millions)
Figure 16. Europe Prostate Cancer Diagnosis and Therapy Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Americas Prostate Cancer Diagnosis and Therapy Value Market Share by Country in 2021
Figure 19. Americas Prostate Cancer Diagnosis and Therapy Consumption Market Share by Type in 2021
Figure 20. Americas Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application in 2021
Figure 21. United States Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Prostate Cancer Diagnosis and Therapy Market Size Market Share by Region in 2021
Figure 26. APAC Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application in 2021
Figure 27. China Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Country in 2021
Figure 34. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type in 2021
Figure 35. Europe Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application in 2021
Figure 36. Germany Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size Market Share by Application in 2021
Figure 44. Egypt Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Prostate Cancer Diagnosis and Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 50. APAC Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 51. Europe Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 53. United States Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Canada Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 57. China Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Japan Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 59. Korea Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 61. India Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Australia Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 63. Germany Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 64. France Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 65. UK Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 66. Italy Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 67. Russia Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Spain Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Israel Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Prostate Cancer Diagnosis and Therapy Market Size 2023-2028 ($ Millions)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...